Alcohol

Alcohol

SCHEMBL3854623

CCCC(C)CO.CCO

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

MMP1MMP13MMP7MMP8polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Alcohol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 6/20 0.94
LMNA P02545 3/20 0.40
ALDH1A1 P00352 2/20 0.38
TDP1 Q9NUW8 2/20 0.37
CHRM1 P11229 1/20 0.33
AKR1A1 P14550 1/20 0.33
CHRM3 P20309 1/20 0.33
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
ADRA1A P35348 1/20 0.33
HRH1 P35367 1/20 0.33
DRD3 P35462 1/20 0.33
SLC6A3 Q01959 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33
CYP3A4 P08684 3/20 0.32
NFKB1 P19838 2/20 0.32
NPSR1 Q6W5P4 2/20 0.32
FDPS P14324 1/20 0.32
METAP1 P53582 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7753346 0.97 TSHR (1.00) TSHRLMNAALDH1A1TDP1CHRM1
SCHEMBL1204819 0.97
SCHEMBL1203795 0.97
SCHEMBL22659 0.97
SCHEMBL10629921 0.94
SCHEMBL10787192 0.94
SCHEMBL8617109 0.94
SCHEMBL10632079 0.94
SCHEMBL10786900 0.94
Ammonia Solution, Strong SCHEMBL11075783 0.94 TSHR (0.94) TSHRLMNAALDH1A1TDP1CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050112739-A1 Method for producing hydrocarbons and oxygen-containing compounds from biomass SWEDISH BIOFUELS AB (SE) 2005-05-26 US claimed
EP-0126266-B1 LOW STRIATION POSITIVE RESIST COMPOSITION MicroSi, Inc. (a Delaware corporation) (US) 1990-03-21 EP claimed
EP-1697287-B1 IMPROVEMENTS IN OR RELATING TO HYDROGENATION EXXONMOBIL CHEM PATENTS INC (US) 2015-08-26 EP disclosed
US-7586017-B2 Hydrogenation EXXONMOBIL CHEMICAL PATENTS INC. (US) 2009-09-08 US disclosed
US-20070161829-A1 Improvements in or relating to hydrogenation EXXONMOBIL CHEMICAL PATENTS INC. 2007-07-12 US disclosed
EP-1697287-A1 IMPROVEMENTS IN OR RELATING TO HYDROGENATION ExxonMobil Chemical Patents Inc. (US) 2006-09-06 EP disclosed
WO-2005058782-A1 IMPROVEMENTS IN OR RELATING TO HYDROGENATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2005-06-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070161829-A1 Improvements in or relating to hydrogenation ADH5, ADH1C, ADH1A TSHR 1518/4885LMNA 4769/4885ALDH1A1 897/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.